Skip to main content
Veterinary Medicines

Osphos 51 mg/ml solution for injection for horses

Authorised
  • Clodronate disodium tetrahydrate

Product identification

Medicine name:
Osphos 51 mg/ml solution for injection for horses
Osphos 51 mg/ml solução injetável para cavalos
Active substance:
  • Clodronate disodium tetrahydrate
Target species:
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Clodronate disodium tetrahydrate
    74.98
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM05BA02
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • Clear glass (type I) vial with siliconized rubber stopper, an aluminium seal and a plastic flip-off cap containing 15 ml of clodronic acid solution.Each cardboard box contains 1 vial

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 924/01/15DFVPT
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0508/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Finland
  • France
  • Germany
  • Hungary
  • Iceland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 26/01/2025
Download

Combined File of all Documents

English (PDF)
Published on: 26/01/2025
Download
Portuguese (PDF)
Published on: 29/01/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."